Gullible Russians exploited by stem cell hucksters
Even though no stem cell treatment — adult or embryonic — has been approved for clinical use in the US or Europe, Russians are flocking to clinic and beauty therapists offering quick cures and cosmetic therapy. The Associated Press even spoke with a 40-year-old gynaecologist from Perm who spent US$20,000 on useless embryonic stem cell injections to cure her multiple sclerosis. (The average monthly wage in Russia is $300.) A clinic in central Moscow is advertising injections of stem cells from aborted foetuses into thighs, buttocks and stomachs to help women get rid of flab and look younger.
Experts say that these unproven procedures could be dangerous and are illegal. What is injected may not be even stem cells. Some clinics are said to be injecting animal stem cells. However, government oversight is so poor in Russia and its regulations so vague that the clinics continue to flourish. Dr Alexander Teplyashin, of a Moscow clinic called Beauty Plaza, acknowledges this. “We are taking advantage of the loopholes in the law,” he told AP. “What is not forbidden is allowed.”
- Prescribe morning-after pills to young teenagers, say US pediatric group - November 30, 2012
- Bahrain sentences protest docs to prison - November 28, 2012
- Terry Pratchett assisted suicide documentary wins International Emmy - November 27, 2012
More Stories
Mortality rates for American kids are rising for the first time in 50 years
US President Joe Biden is so concerned about the future of American children that he inserted a mandate for affordable...
Will Pope Francis be composted?
Will Pope Francis be composted instead of buried in St Peter’s Basilica in Rome with his predecessors? It’s unlikely. But...
The virtues and the vices of the outrageous
A Norwegian bioethicist, Anna Smajdor, recently set out a case for “Whole Body Gestational Donation” – using the wombs of...
More than 200 people have been treated with experimental CRISPR therapies
Scientists believe that CRISPR gene editing technologies will transform medicine. But how many people have been treated so far? According...
Asia-Pacific IVF market could reach US$46 billion by 2031
According to a market survey by Allied Market Research, IVF is booming in the Asia-Pacific region. The market size was...
Third global summit on human genome editing: Moving on after the He experiment
The much anticipated Third International Summit on Human Genome Editing was held in London earlier this month to explore the...